BioAtla BCAB
OTC BCAB
$1.80 -0.01 (-0.55%)
At close: Nov 10, 2026 · 4:00 PM EST

BioAtla (BCAB) Total Debt (2020 - 2021)

Updated

BioAtla's Total Debt was $682,000 in Q2 2021, unchanged from the prior quarter.

Analysis

BioAtla (BCAB) Total Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 BioAtla 2.99 Mn -15.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 682,000.00
Mar 31, 2021 682,000.00
Dec 31, 2020 682,000.00
API Access

BioAtla Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=BCAB&period=max&api_key=YOUR_API_KEY